Learning from combination HIV prevention programmes to face COVID-19 emerging pandemic
Article Sidebar
Main Article Content
Before a vaccine against SARS-CoV-2 became available, several measures to control COVID-19 pandemic are necessary. Analogously, in the absence of an available vaccine, Combination HIV Prevention Programmes have consolidated a large experience of biomedical, behavioral and structural interventions suitable for several epidemiological settings. Adaptation of such experiences can organize mid-term and long-term responses to face COVID-19
- COVID-19
- Coronavirus
- SARS Virus
- Condoms
- Acquired Immunodeficiency Syndrome
- Pandemics
- Asymptomatic Infections
- Personal Protective Equipment
- severe acute respiratory syndrome coronavirus 2
- Severe Acute Respiratory Syndrome
- Immunization
- VIH
Ricardo Palacios, Clinical Research and Development Manager, Division of Clinical Trial and Pharmacovigilance, Instituto Butantan São Paulo, Brazil
Clinical Research Medical Director. Instituto Butantan, São Paulo, Brazil
https://orcid.org/0000-0002-1410-8579
Education:
Physician, Universidad Nacional de Colombia
PhD in Infectious Diseases, UNIFESP / Escola Paulista de Medicina
Social Scientist and Specialization in Bioethics, University of São Paulo
Investigation area
Development of vaccines, bioethics.
Recent Articles.
- Shah SK, Miller FG, Darton TC, Duenas D, Emerson C, Fernandez Lynch H, Jamrozik E, Jecker NS, Kamuya D, Kapulu M, Kimmelman J, MacKay M, Memoli MJ, Murphy SC, Palacios R, Richie TR, Roestenberg M, Saxena A, Saylor M, Selgelid MJ, Vaswani V, Rid A. Ethics of controlled human infection to study COVID-19. Science (80- ). May 2020: eabc1076. https://doi.org/10.1126/science.abc1076
- Kallas EG, Precioso AR, Palacios R, Thomé B, Braga PE, Vanni T, Campos LMA, Ferrari L, Mondini G, da Graça Salomão M, da Silva A, Espinola HM, do Prado Santos J, Santos CLS, Timenetsky MDCST, Miraglia JL, Gallina NMF, Weiskopf D, Sette A, Goulart R, Salles RT, Maestri A, Sallum AME, Farhat SCL, Sakita NK, Ferreira JCOA, Silveira CGT, Costa PR, Raw I, Whitehead SS, Durbin AP, Kalil J. Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial. Lancet Infect Dis. 2020 Mar 24. pii: S1473-3099(20)30023-2. https://doi.org/10.1016/S1473-3099(20)30023-2
- Palacios R, Shah SK.When could human challenge trials be deployed to combat emerging infectious diseases? Lessons from the case of a Zika virus human challenge trial. Trials. 2019 Dec 19;20(Suppl 2):702. https://doi.org/10.1186/s13063-019-3843-0
- Palacios R. Forgotten, but not forgiven: facing immunization challenges in the 21 st century. Colomb Med (Cali). 2018 Sep 30;49(3):189-192. https://doi.org/10.25100/cm.v49i3.4154
Augusto Mathias, University of São Paulo, São Paulo, Brazil
Universidade de São Paulo, Facultad de Medicina, Departamento de Medicina Preventiva, Programa de Salud Colectiva, São Paulo, Brasil
https://orcid.org/0000-0002-5896-9223
Education:
Psychologist, FMU; Biologist, UNESP
MSc in Preventive Medicine, Universidade de São Paulo
cPhD Preventive Medicine Program, School of Medicine, Universidade de São Paulo
Clinical experience.
Clinical Psychologist with emphasis in psychoanalysis
Investigation area
HIV, HIV Prevention, Gender Sexuality Minorities, Social Determinants of Health, Illicit Drugs
Selected Items.
- Mathias A, Santos LA, Grangeiro A, Couto MT. Síntesis temática de estudios cualitativos de prevención del VIH en hombres que tienen sexo con hombres (HSH). Colombia Medica, v. 50, p. 201-214, 2019. https://doi.org/10.25100/cm.v50i3.4078
- Santos LA, Couto MT, Mathias A, Grangeiro A. Hombres heterosexualmente activos, masculinidades, prevención de infección por VIH y búsqueda de profilaxis posexposición sexual consentida. Salud Colectiva, v. 15, p. e2144, 2019. https://doi.org/10.18294/sc.2019.2144
- Ferraz D, Couto MT, Zucchi EM, Calazans GJ, Santos LA, Mathias A, Grangeiro A. AIDS- and sexuality-related stigmas underlying the use of post-exposure prophylaxis for HIV in Brazil: findings from a multicentric study. Sexual and Reproductive Health Matters, v. 27, p. 1650587, 2019. https://doi.org/10.1080/26410397.2019.1650587
- Avelino-Silva VI, Miyaji KT, Mathias A, Costa DA, De Carvalho Dias JZ, Lima SB, Simões M, Freire MS, Caiaffa-Filho HH, Hong MA, Lopes MH, Sartori AM, Kallas EG.CD4/CD8 Ratio Predicts Yellow Fever Vaccine-Induced Antibody Titers in Virologically Suppressed HIV-Infected Patients. Journal of Acquired Immune Deficiency Syndromes (1999), v. 71, p. 189-195, 2016. https://doi.org/10.1097/QAI.0000000000000845
Downloads
Accepted 2020-04-18
Published 2020-05-07
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use